SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emanuela Taioli, Andrea S. Wolf, Marlene Camacho-Rivera, Raja M. Flores, Women With Malignant Pleural Mesothelioma Have a Threefold Better Survival Rate Than Men, The Annals of Thoracic Surgery, 2014, 98, 3, 1020

    CrossRef

  2. 2
    D. W. Henderson, G. Reid, S. C. Kao, N. van Zandwijk, S. Klebe, Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA, Journal of Clinical Pathology, 2013, 66, 10, 854

    CrossRef

  3. 3
    S. Bolukbas, M. Eberlein, N. Kudelin, M. Demes, S. Stallmann, A. Fisseler-Eckhoff, J. Schirren, Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma, European Journal of Cardio-Thoracic Surgery, 2013, 44, 1, 119

    CrossRef

  4. 4
    S. C.-H. Kao, S. Clarke, J. Vardy, P. Corte, C. Clarke, N. Zandwijk, Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia, Internal Medicine Journal, 2013, 43, 4
  5. 5
    Kenichi Gemba, Nobukazu Fujimoto, Keisuke Aoe, Katsuya Kato, Yukio Takeshima, Kouki Inai, Takumi Kishimoto, Treatment and survival analyses of malignant mesothelioma in Japan, Acta Oncologica, 2013, 52, 4, 803

    CrossRef

  6. 6
    Steven C. Kao, Janette Vardy, Mark Chatfield, Peter Corte, Nick Pavlakis, Christopher Clarke, Nico van Zandwijk, Stephen Clarke, Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board, Clinical Lung Cancer, 2013, 14, 1, 70

    CrossRef

  7. 7
    S. M. Gelvez-Zapata, D. Gaffney, M. Scarci, A. S. Coonar, What is the survival after surgery for localized malignant pleural mesothelioma?, Interactive CardioVascular and Thoracic Surgery, 2013, 16, 4, 533

    CrossRef

  8. 8
    Lucia Fazzo, Marco De Santis, Giada Minelli, Caterina Bruno, Amerigo Zona, Alessandro Marinaccio, Susanna Conti, Pietro Comba, Pleural mesothelioma mortality and asbestos exposure mapping in Italy, American Journal of Industrial Medicine, 2012, 55, 1
  9. 9
    S van der Bij, H Koffijberg, J A Burgers, P Baas, M J van de Vijver, B A J M de Mol, K G M Moons, Prognosis and prognostic factors of patients with mesothelioma: a population-based study, British Journal of Cancer, 2012, 107, 1, 161

    CrossRef

  10. 10
    Nina Erčulj, Viljem Kovač, Julija Hmeljak, Alenka Franko, Metoda Dodič-Fikfak, Vita Dolžan, The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma, Pharmacogenetics and Genomics, 2012, 22, 1, 58

    CrossRef

  11. 11
    Anthony Linton, Janette Vardy, Stephen Clarke, Nico van Zandwijk, The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma, Critical Reviews in Oncology/Hematology, 2012, 84, 2, 200

    CrossRef

  12. 12
    Jennifer E. Below, Nancy J. Cox, Naomi K. Fukagawa, Ari Hirvonen, Joseph R. Testa, Factors that Impact Susceptibility to Fiber-Induced Health Effects, Journal of Toxicology and Environmental Health, Part B, 2011, 14, 1-4, 246

    CrossRef

  13. 13
    Steven Chuan-Hao Kao, Sonja Klebe, Douglas W. Henderson, Glen Reid, Mark Chatfield, Nicola J. Armstrong, Tristan D. Yan, Janette Vardy, Stephen Clarke, Nico van Zandwijk, Brian McCaughan, Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy, Journal of Thoracic Oncology, 2011, 6, 11, 1923

    CrossRef

  14. 14
    Jan P. van Meerbeeck, Arnaud Scherpereel, Veerle F. Surmont, Paul Baas, Malignant pleural mesothelioma: The standard of care and challenges for future management, Critical Reviews in Oncology/Hematology, 2011, 78, 2, 92

    CrossRef

  15. 15
    B. Davidson, The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma, Cytopathology, 2011, 22, 1
  16. 16
    Andrea S. Wolf, William G. Richards, Tamara R. Tilleman, Lucian Chirieac, Shelley Hurwitz, Raphael Bueno, David J. Sugarbaker, Characteristics of Malignant Pleural Mesothelioma in Women, The Annals of Thoracic Surgery, 2010, 90, 3, 949

    CrossRef

  17. 17
    Raja M. Flores, Elyn Riedel, Jessica Scott Donington, William Alago, Ugonna Ihekweazu, Lee Krug, Kenneth Rosenzweig, Prasad S. Adusumilli, Michele Carbone, Harvey I. Pass, Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population, Journal of Thoracic Oncology, 2010, 5, 10, 1649

    CrossRef

  18. 18
    Hiroshi Hirano, Takashi Fujisawa, Koichi Maekawa, Eriko Ohkubo, Akira Okimura, Kozo Kuribayashi, Takashi Nakano, Keiji Nakasho, Takashi Nishigami, Malignant mesothelioma of the peritoneum: case reports and immunohistochemical findings including Ki-67 expression, Medical Molecular Morphology, 2010, 43, 1, 53

    CrossRef

  19. 19
    Michael T. Milano, Hong Zhang, Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, 2010, 5, 11, 1841

    CrossRef

  20. 20
    Dayron Rodríguez, Michael C. Cheung, Nadine Housri, Leonidas G. Koniaris, Malignant abdominal mesothelioma: Defining the role of surgery, Journal of Surgical Oncology, 2009, 99, 1
  21. 21
    Wendy W. Huebner, Nancy C. Wojcik, Gail Jorgensen, Susan P. Marcella, Mark J. Nicolich, Mortality Patterns and Trends Among 127,266 U.S.-Based Men in a Petroleum Company: Update 1979–2000, Journal of Occupational and Environmental Medicine, 2009, 51, 11, 1333

    CrossRef

  22. 22
    B. CLIN, F. MORLAIS, B. DUBOIS, A.-V. GUIZARD, N. DESOUBEAUX, M.-F. MARQUIGNON, C. RAFFAELLI, C. PARIS, F. GALATEAU-SALLE, G. LAUNOY, M. LETOURNEUX, Occupational asbestos exposure and digestive cancers – a cohort study, Alimentary Pharmacology & Therapeutics, 2009, 30, 4
  23. 23
    Dean A Fennell, Giovanni Gaudino, Kenneth J O'Byrne, Luciano Mutti, Jan van Meerbeeck, Advances in the systemic therapy of malignant pleural mesothelioma, Nature Clinical Practice Oncology, 2008, 5, 3, 136

    CrossRef

  24. 24
    Alessandro Marinaccio, Alberto Scarselli, Alessandra Binazzi, Pierluigi Altavista, Stefano Belli, Marina Mastrantonio, Roberto Pasetto, Raffaella Uccelli, Pietro Comba, Asbestos related diseases in Italy: an integrated approach to identify unexpected professional or environmental exposure risks at municipal level, International Archives of Occupational and Environmental Health, 2008, 81, 8, 993

    CrossRef

  25. 25
    Sonja Klebe, Annabelle Mahar, Douglas W Henderson, Victor L Roggli, Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review, Modern Pathology, 2008, 21, 9, 1084

    CrossRef

  26. 26
    Lilach Kleinberg, Agnes Kathrine Lie, Vivi Ann Flørenes, Jahn M. Nesland, Ben Davidson, Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma, Human Pathology, 2007, 38, 7, 986

    CrossRef

  27. 27
    Stine Sivertsen, Rivka Hadar, Sivan Elloul, Lina Vintman, Carlos Bedrossian, Reuven Reich, Ben Davidson, Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression, Lung Cancer, 2006, 54, 3, 309

    CrossRef

  28. 28
    Hannelore Goeminne, Jan P van Meerbeeck, Pemetrexed in thoracic cancer, Expert Opinion on Pharmacotherapy, 2006, 7, 7, 917

    CrossRef

  29. 29
    Carmine Pinto, Antonella Marino, Vincenzo De Pangher Manzini, Giovanni Benedetti, Domenico Galetta, Paola Mazzanti, Guido Del Conte, Davide dell’Amore, Edera Piana, Stefania Giaquinta, Massimo Lopez, Andrea Martoni, Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma, Lung Cancer, 2006, 52, 2, 199

    CrossRef

  30. 30
    Ben Davidson, Björn Risberg, Aasmund Berner, Carlos W.M. Bedrossian, Reuven Reich, The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma, Seminars in Diagnostic Pathology, 2006, 23, 1, 35

    CrossRef

  31. 31
    Lina Vintman, Søren Nielsen, Aasmund Berner, Reuven Reich, Ben Davidson, Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells, Cancer, 2005, 103, 11
  32. 32
    Alessandro Marinaccio, Fabio Montanaro, Marina Mastrantonio, Raffaella Uccelli, Pierluigi Altavista, Massimo Nesti, Adele Seniori Costantini, Giuseppe Gorini, Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age-period-cohort models, International Journal of Cancer, 2005, 115, 1
  33. 33
    Ben Davidson, Lina Vintman, Søren Nielsen, Reuven Reich, Aasmund Berner, Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma—a new model for the study of tumor biology and disease progression, Lung Cancer, 2005, 49, S89

    CrossRef

  34. 34
    G Gorini, G De Gregorio, S Silvestri, E Chellini, V Cupelli, A Seniori Costantini, Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988???2000: a population-based study, European Journal of Cancer Prevention, 2005, 14, 3, 195

    CrossRef

  35. 35
    Massimo Nesti, Alessandro Marinaccio, Elisabetta Chellini, Malignant mesothelioma in Italy, 1997, American Journal of Industrial Medicine, 2004, 45, 1
  36. 36
    V. Villena Garrido, A. López Encuentra, J. Echave-Sustaeta, C. Álvarez Martínez, L. Rey Terrón, M.T. Sotelo, C. Ballestín, Mesotelioma pleural: experiencia durante 9 años y descripción de 62 casos, Archivos de Bronconeumología, 2004, 40, 5, 203

    CrossRef

  37. 37
    Richard F Mould, Michael Lahanas, Bernard Asselain, David Brewster, Sjaak A Burgers, Ronald A M Damhuis, Yann De Rycke, Valerio Gennaro, Neonila Szeszenia-Dabrowska, Methodology for lognormal modelling of malignant pleural mesothelioma survival time distributions: a study of 5580 case histories from Europe and USA, Physics in Medicine and Biology, 2004, 49, 17, 3991

    CrossRef

  38. 38
    V. Villena Garrido, A. López Encuentra, J. Echave-Sustaeta, C. Álvarez Martínez, L. Rey Terrón, M.T. Sotelo, C. Ballestín, Pleural Mesothelioma: Experience With 62 Cases in 9 Years, Archivos de Bronconeumología ((English Edition)), 2004, 40, 5, 203

    CrossRef

  39. 39
    Jacobus A Burgers, Ronald A.M Damhuis, Prognostic factors in malignant mesothelioma, Lung Cancer, 2004, 45, S49

    CrossRef

  40. 40
    A Marinaccio, M Nesti, Analysis of survival of mesothelioma cases in the Italian register (ReNaM), European Journal of Cancer, 2003, 39, 9, 1290

    CrossRef

  41. 41
    Scott A. J. Kerrigan, Philip Cagle, Andrew Churg, Malignant Mesothelioma of the Peritoneum Presenting as an Inflammatory Lesion, The American Journal of Surgical Pathology, 2003, 27, 2, 248

    CrossRef

  42. 42
    Paul Baas, Predictive and prognostic factors in malignant pleural mesothelioma, Current Opinion in Oncology, 2003, 15, 2, 127

    CrossRef

  43. 43
    Jeremy P.C. Steele, Prognostic factors in mesothelioma, Seminars in Oncology, 2002, 29, 1, 36

    CrossRef

  44. 44
    Anders Thylén, Anders Hjerpe, Gunnar Martensson, Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma, Cancer, 2001, 92, 5
  45. 45
    Giovanni Luca Ceresoli, Laura Deborah Locati, Andrés José Marı́a Ferreri, Cesare Cozzarini, Paolo Passoni, Giulio Melloni, Piero Zannini, Angelo Bolognesi, Eugenio Villa, Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma, Lung Cancer, 2001, 34, 2, 279

    CrossRef

  46. 46
    Gamal H. Eltabbakh, M. Steven Piver, Ronald E. Hempling, Fernando O. Recio, Marilyn E. Intengen, Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma, Journal of Surgical Oncology, 1999, 70, 1
  47. 47
    Hugo Schouwink, Catharina M. Korse, Johannes M.G. Bonfrer, Augustinus A.M. Hart, Paul Baas, Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma, Lung Cancer, 1999, 25, 1, 25

    CrossRef

  48. 48
    Rika Kawanishi, Hiroshi Ueoka, Masahiro Tabata, Takuo Shibayama, Tomofumi Yano, Akio Matsushita, Kenichi Chikamori, Hiroyuki Kohara, Mine Harada, Taisuke Ohnoshi, Spontaneous regression of malignant pleural mesothelioma, International Journal of Clinical Oncology, 1997, 2, 2, 118

    CrossRef

  49. 49
    Valerie W. Rusch, A proposed new International TNM Staging System for malignant pleural mesothelioma from the International Mesothelioma Interest Group, Lung Cancer, 1996, 14, 1, 1

    CrossRef

  50. 50
    Valerie W. Rusch, Ennapadam Venkatraman, The importance of surgical staging in the treatment of malignant pleural mesothelioma, The Journal of Thoracic and Cardiovascular Surgery, 1996, 111, 4, 815

    CrossRef

  51. 51
    Hiroshi Takita, Thomas J. Dougherty, Intracavitary photodynamic therapy for malignant pleural mesothelioma, Seminars in Surgical Oncology, 1995, 11, 5
  52. 52
    T. R. Driscoll, R. Thompson, G. J. Baker, D. A. Ferguson, S. Daniels, J. Leigh, J. Lee, Clinical aspects of malignant mesothelioma in Australia, Australian and New Zealand Journal of Medicine, 1993, 23, 1
  53. 53
    Vincenzo de Pangher Manzini, Alessandro Brollo, Silvia Franceschi, Marina de Matthaeis, Renato Talamini, Claudio Bianchi, Prognostic factors of malignant mesothelioma of the pleura, Cancer, 1993, 72, 2
  54. 54
    C. Boutin, F. Rey, J. Gouvernet, J. R. Viallat, Ph. Astoul, V. Ledoray, Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging, Cancer, 1993, 72, 2
  55. 55
    Lauri Tammilehto, Timo Tuomi, Marianne Tiainen, Jukka Rautonen, Sakari Knuutila, Seppo Pyrhönen, Karin Mattson, Malignant mesothelioma: Clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients, European Journal of Cancer, 1992, 28, 8-9, 1373

    CrossRef

  56. 56
    Lauri Tammilehto, Malignant mesothelioma: Prognostic factors in a prospective study of 98 patients, Lung Cancer, 1992, 8, 3-4, 175

    CrossRef

  57. 57
    Eliezer Schwartz, Chaim Maayan, Meir Mouallem, Santiago Engelberg, Eitan Friedman, Malignant peritoneal mesothelioma: Long-term spontaneous clinical remission, Medical and Pediatric Oncology, 1991, 19, 4